New Triple-Therapy combo tested in fight against rectal cancer
NCT ID NCT07154316
Summary
This study is testing two different radiation treatment schedules, both combined with chemotherapy, an immunotherapy drug, and an anti-inflammatory pill, for people with a specific type of locally advanced rectal cancer. The goal is to see which combination is better at completely eliminating the tumor and preserving the anus, avoiding major surgery. Researchers will also track side effects and how long patients live without the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anyang Tumor Hospital
RECRUITINGAnyang, Henan, 455100, China
Contact Phone: •••-•••-••••
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fujian Provincial Cancer Hospital
RECRUITINGFuzhou, Fujian, 350000, China
Contact Phone: •••-•••-••••
-
The First Affiliated Hospital of Shandong First Medical University
RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-••••
-
Yunnan Cancer Hospital
RECRUITINGKunming, 650118, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.